Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin and Behavioral Sleep Intervention in Bipolar Disorder
NCT06226025Phase 2Recruiting
- Start
- Aug 2024
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in bipolar disorder (BD) and delayed sleep-wake phase disorder (DSPD) (2 arms). Primary endpoint: Dim Light Melatonin Onset at 4 weeks. Started Aug 2024; status: recruiting.
02
Conditions
bipolar disorder (BD)delayed sleep-wake phase disorder (DSPD)
Beyond the preview
Go deeper on NCT06226025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06226025.